Description: Hubei Biocause Pharmaceutical Co., Ltd. primarily provides life and motor insurance products in China. It also engages in the pharmaceutical, chemical, and new energy fuel businesses. In addition, the company is involved in the contract research and production of APIs, intermediates, and formulations, including tablets, granules, capsules, etc.; and provision of chemicals comprising dimethyl ether gas and a-chloropropionyl chloride. It exports its products to approximately 85 countries, including the United States, the European Union, and internationally. The company is based in Jingmen, China.
Home Page: www.biocause.com
122-132 Yangwan Road
Jingmen,
448000
China
Phone:
86 27 6565 1730
Officers
| Name | Title |
|---|---|
| Ms. Wenxia Zhou | Vice Chairman & GM |
| Mr. Dali Chen | CFO & Director |
| Mr. Fei Long | Sec. of the Board & Non-Independent Director |
Exchange: SHE
Country: CN
Currency: Renminbi (¥)
| GIC Sector: | Financials |
|---|---|
| GIC Group: | Insurance |
| GIC Industry: | Insurance |
| GIC Sub-Industry: | Life & Health Insurance |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 41.875 |
| Price-to-Book MRQ: | 0.7542 |
| Price-to-Sales TTM: | 0.3131 |
| IPO Date: | 1996-11-12 |
| Fiscal Year End: | December |
| Full Time Employees: | 2239 |